Literature DB >> 21617700

Refining the diagnosis of T-cell large granular lymphocytic leukemia by combining distinct patterns of antigen expression with T-cell clonality studies.

R S Ohgami1, J K Ohgami, I T Pereira, G Gitana, J L Zehnder, D A Arber.   

Abstract

T-cell large granular lymphocytic (LGL) leukemia is a complex diagnosis, requiring persistent clonal expansions of LGLs, and cytopenias. Often the diagnosis is unclear as non-clonal expansions of LGLs commonly occur in reactive conditions. To better understand T-LGL leukemia, we performed a comprehensive clinicopathologic analysis of 85 patients with LGL expansions. Interestingly, distinct CD8+(dim)/CD57+ populations, seen by flow cytometry, were significantly associated with clonal T-LGL leukemia (P < 0.001) as well as neutropenia (median absolute neutrophil count (ANC) 1.45 vs 3.19 × 10(9)/l; P = 0.0017). Furthermore, cases with distinct CD8+(dim)/CD57+ populations and monoclonal T cells had even lower ANCs (median ANC 1.41 × 10(9)/l; P = 0.001) compared with cases without these dual criteria. Additionally, complete or partial loss of CD5 expression was independently associated with clonal T-LGL leukemia (P<0.001) and neutropenia (median ANC 1.41 vs 2.70 × 10(9)/l; P = 0.002). This study describes specific immunophenotypic parameters to better define clonal cases of T-LGL leukemia associated with significant neutropenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21617700     DOI: 10.1038/leu.2011.107

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics.

Authors:  Min Shi; Horatiu Olteanu; Dragan Jevremovic; Rong He; David Viswanatha; Heidi Corley; Pedro Horna
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

2.  Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.

Authors:  Fang Yang; Tengfei Liu; Haiyan Zhao; Zhiyan Hu; Liwei Xiao; Yanping Liu; Xiaoyan Wang; Zuguo Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.

Authors:  Robert S Ohgami; Lisa Ma; Jason D Merker; Jason R Gotlib; Iris Schrijver; James L Zehnder; Daniel A Arber
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

4.  Survival and associated comorbidities in inclusion body myositis.

Authors:  Elie Naddaf; Shahar Shelly; Jay Mandrekar; Alanna M Chamberlain; E Matthew Hoffman; Floranne C Ernste; Teerin Liewluck
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

5.  STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features.

Authors:  Noemí Muñoz-García; María Jara-Acevedo; Carolina Caldas; Paloma Bárcena; Antonio López; Noemí Puig; Miguel Alcoceba; Paula Fernández; Neus Villamor; Juan A Flores-Montero; Karoll Gómez; María Angelina Lemes; Jose Carlos Hernández; Iván Álvarez-Twose; Jose Luis Guerra; Marcos González; Alberto Orfao; Julia Almeida
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

Review 6.  Inclusion body myositis: Update on the diagnostic and therapeutic landscape.

Authors:  Elie Naddaf
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

Review 7.  Mutations in the signal transducer and activator of transcription family of genes in cancer.

Authors:  Nahid Shahmarvand; Alexandra Nagy; Jahanbanoo Shahryari; Robert S Ohgami
Journal:  Cancer Sci       Date:  2018-03-02       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.